2m 2m 2m 2m 2m 2m 2m
LUCID DIAGNOSTCS (LUCD)
NASDAQ
$1.02+$0.02 (+1.59%)
Price as of Jun 03, 2026 7:55 PM EDT- $196.5MMarket Cap
- -17.62%1-Year Change
- Medical DevicesIndustry
LUCID DIAGNOSTCS (LUCD)
$1.02+$0.02 (+1.59%)
LUCD | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.00 | ||
Change | $0.00 (0.00%) | ||
Open | $1.03 | ||
High | $1.05 | ||
Low | $1.00 | ||
Previous Close | $1.03 | ||
Volume | 816,670 | ||
30-Day Average Volume | 957,890 | ||
1-Week Change | -7.21% | ||
1-Month Change | -5.50% | ||
1-Year Change | -18.25% | ||
3-Year Change | -38.69% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 190.8M | ||
Total Assets | $34.1M | ||
Market Cap | $196.5M | ||
Enterprise Value | $193.8M | ||
Period: QTR TTM FY | |||
Revenue | $1.3M | ||
Net Income | -$13.9M | ||
Free Cash Flow | -$12.3M | ||
EBIT | -$13.9M | ||
EBITDA | -$13.7M | ||
Net Working Capital | $2.0M | ||
EPS | -$0.17 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 154 | ||
P/B | 49 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | -16 | ||
Price/Operating Cash Flow | -16 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue